LATENT TUBERCULOSIS
Clinical trials for LATENT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-month TB pill regimen tested for kidney transplant hopefuls
Disease control OngoingThis study tests a 1-month course of three medicines (isoniazid, rifapentine, and vitamin B6) to treat latent tuberculosis in 25 adults with end-stage kidney disease who are candidates for a kidney transplant. The goal is to see if this shorter treatment is safe and easy to compl…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE4 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
3-Minute video aims to boost latent TB treatment completion
Knowledge-focused OngoingThis study tests whether a 3-minute educational video can help more people complete their treatment for latent tuberculosis (LTBI). About 1,898 adults at Kaiser Permanente Southern California are randomly assigned to receive the video or standard care. The main goal is to see if …
Matched conditions: LATENT TUBERCULOSIS
Phase: NA • Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:17 UTC